IKT·45719W205·US·equity·Healthcare - Biotechnology-13D/G
IKT (INHIBIKASE THERAPEUTICS INC) is held by 57 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($10.6M), Blackstone Inc. ($10M), MILLENNIUM MANAGEMENT LLC ($4.9M). Net institutional sentiment: Bullish.
See how IKT's score breaks down across 4 SEC sources
Showing 1-20 of 61
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer